Esketamin modulira postoperativne biohemijske markere oksidativnog stresa, upale i imunološke disregulacije u laparoskopskoj hirurgiji kolorektalnog karcinoma
Esketamine Alters Biochemical and Immune Markers in Colorectal Surgery
Sažetak
Background: Laparoscopic colorectal cancer surgery, while minimally invasive, induces systemic oxidative stress, inflammation, and immune dysfunction through surgical trauma and anesthesia-related stress. Esketamine, an NMDA receptor antagonist with antioxidant and anti-inflammatory properties, may mitigate these biochemical perturbations. This study evaluated esketamine’s effects on serum biomarkers of oxidative stress (glutathione, catalase, malondialdehyde, superoxide dismutase), inflammatory mediators (TNF-α, CRP, IL-6), and T lymphocyte subsets in patients undergoing laparoscopic colorectal cancer resection.
Methods: In this randomized controlled trial, 150 stage I-II colorectal cancer patients were allocated to esketamine (0.25 mg/kg bolus + 0.12 mg/kg/h infusion) or control (saline) groups during standardized anesthesia. Pre- and postoperative serum levels of oxidative stress markers (GSH, CAT, MDA, SOD), inflammatory cytokines (TNF-α, CRP, IL-6), and immune cell subsets (CD3+, CD4+, CD8+, CD4+/CD8+ ratio) were quantified via ELISA and flow cytometry. Statistical analysis compared intergroup differences using t-tests and chi-square tests.
Results: Postoperatively, the esketamine group exhibited significantly attenuated oxidative stress, with higher GSH (72.43 ± 6.63 vs. 60.16 ± 5.57 mg/mL, P < 0.05), CAT (92.56 ± 8.31 vs. 82.81 ± 7.75 U/mL), and SOD (84.53 ± 8.02 vs. 69.93 ± 7.05 nU/mL), alongside lower MDA (6.41 ± 0.52 vs. 9.52 ± 0.63 mmol/L). Pro-inflammatory cytokines were reduced (TNF-α: 40.32 ± 4.84 vs. 54.37 ± 5.80 pg/mL; IL-6: 50.83 ± 5.05 vs. 82.38 ± 8.46 pg/mL, P < 0.05). Immune function preservation was evident through elevated CD3+ (45.18 ± 5.01% vs. 37.05 ± 4.92%) and CD4+ T cells (26.51 ± 2.76% vs. 19.78 ± 2.09%), with a balanced CD4+/CD8+ ratio (1.12 ± 0.12 vs. 0.72 ± 0.09).
Conclusion: Esketamine-based anesthesia significantly ameliorates postoperative oxidative damage, suppresses inflammatory cytokine release, and preserves cellular immune homeostasis, as evidenced by targeted biochemical and immunological analyses. These findings highlight esketamine’s role in modulating perioperative biochemical pathways, potentially enhancing recovery in colorectal cancer surgery.
Reference
2. Patel SG, Dominitz JA. Screening for Colorectal Cancer. Ann Intern Med 2024; 177(4): ITC49-64.
3. Kastrinos F, Kupfer SS, Gupta S. Colorectal Cancer Risk Assessment and Precision Approaches to Screening: Brave New World or Worlds Apart? Gastroenterology 2023; 164(5): 812-27.
4. Li N, Lu B, Luo C, Cai J, Lu M, Zhang Y, et al. Incidence, mortality, survival, risk factor and screening of colorectal cancer: A comparison among China, Europe, and northern America. Cancer Lett 2021; 522: 255-68.
5. Cao W, Chen HD, Yu YW, Li N, Chen WQ. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020. Chinese Med J-Peking 2021; 134(7): 783-91.
6. Kuboki Y, Fakih M, Strickler J, Yaeger R, Masuishi T, Kim EJ, et al. Sotorasib with panitumumab in chemotherapy-refractory KRAS(G12C)-mutated colorectal cancer: a phase 1b trial. Nat Med 2024; 30(1): 265-70.
7. Heide T, Househam J, Cresswell GD, Spiteri I, Lynn C, Mossner M, et al. The co-evolution of the genome and epigenome in colorectal cancer. Nature 2022; 611(7937): 733-43.
8. Biller LH, Schrag D. Diagnosis and Treatment of Metastatic Colorectal Cancer: A Review. Jama-J Am Med Assoc 2021; 325(7): 669-85.
9. Kuipers EJ, Grady WM, Lieberman D, Seufferlein T, Sung JJ, Boelens PG, et al. Colorectal cancer. Nat Rev Dis Primers 2015; 1: 15065.
10. Buccafusca G, Proserpio I, Tralongo AC, Rametta GS, Tralongo P. Early colorectal cancer: diagnosis, treatment and survivorship care. Crit Rev Oncol Hemat 2019; 136: 20-30.
11. Wang Y, Yang JW, Yan SY, Lu Y, Han JG, Pei W, et al. Electroacupuncture vs Sham Electroacupuncture in the Treatment of Postoperative Ileus After Laparoscopic Surgery for Colorectal Cancer: A Multicenter, Randomized Clinical Trial. Jama Surg 2023; 158(1): 20-7.
12. Becattini C, Pace U, Pirozzi F, Donini A, Avruscio G, Rondelli F, et al. Rivaroxaban vs placebo for extended antithrombotic prophylaxis after laparoscopic surgery for colorectal cancer. Blood 2022; 140(8): 900-8.
13. Medeiros GC, Gould TD, Prueitt WL, Nanavati J, Grunebaum MF, Farber NB, et al. Blood-based biomarkers of antidepressant response to ketamine and esketamine: A systematic review and meta-analysis. Mol Psychiatr 2022; 27(9): 3658-69.
14. Taillefer DLT, Jullien A, Yrondi A, Cestac P, Montastruc F. Reporting of harms in clinical trials of esketamine in depression: a systematic review. Psychol Med 2023; 53(10): 4305-15.
15. Swainson J, Thomas RK, Archer S, Chrenek C, MacKay MA, Baker G, et al. Esketamine for treatment resistant depression. Expert Rev Neurother 2019; 19(10): 899-911.
16. Wang T, Weng H, Zhou H, Yang Z, Tian Z, Xi B, et al. Esketamine alleviates postoperative depression-like behavior through anti-inflammatory actions in mouse prefrontal cortex. J Affect Disorders 2022; 307: 97-107.
17. Liu J, Wang T, Song J, Cao L. Effect of esketamine on postoperative analgesia and postoperative delirium in elderly patients undergoing gastrointestinal surgery. Bmc Anesthesiol 2024; 24(1): 46.
18. Pelishenko IA, Letskii VB, Dediurin AM, Galushkin AN, Tikhonova EI. [Polarographically active fraction of alpha 1-unstable glycoprotein in the blood serum during the malignant process]. Eksp Onkol 1988; 10(2): 34-7.
19. Weitz J, Koch M, Debus J, Hohler T, Galle PR, Buchler MW. Colorectal cancer. Lancet 2005; 365(9454): 153-65.
20. Wang K, Wu M, Xu J, Wu C, Zhang B, Wang G, et al. Effects of dexmedetomidine on perioperative stress, inflammation, and immune function: systematic review and meta-analysis. Brit J Anaesth 2019; 123(6): 777-94.
21. Hughes LM, Irwin MG, Nestor CC. Alternatives to remifentanil for the analgesic component of total intravenous anaesthesia: a narrative review. Anaesthesia 2023; 78(5): 620-5.
22. Jelen LA, Young AH, Stone JM. Ketamine: A tale of two enantiomers. J Psychopharmacol 2021; 35(2): 109-23.
23. Mion G, Himmelseher S. Esketamine: Less Drowsiness, More Analgesia. Anesth Analg 2024; 139(1): 78-91.
Sva prava zadržana (c) 2025 Peng Chen, Kun Qian, Kairun Zhu, Xiaoqing Lu, Dajin Liu
Ovaj rad je pod Creative Commons Autorstvo 4.0 međunarodnom licencom.
The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.